Host |
Rabbit and Mouse |
Clone |
13H4 + ZM70 |
Format |
Ready-to-use |
Reactivity |
- |
Method |
P |
Positive control |
Prostate carcinoma. |
Dilution |
- |
Isotype |
IgG, IgG1a/k |
Immunogen |
Human AMACR (P504S) and p63 polypeptides |
Localization |
Cytoplasm and Nucleus |
AMACR + p63
|
13H4 + ZM70 |
7 ml |
Ready-to-use |
CE/IVD |
Z2008MRP |
-
|
Host |
Rabbit and Mouse |
Clone |
13H4 + ZM70 |
Format |
Concentrate |
Reactivity |
- |
Method |
P |
Positive control |
Prostate carcinoma. |
Dilution |
1:50 |
Isotype |
IgG, IgG1a/k |
Immunogen |
Human AMACR (P504S) and p63 polypeptides |
Localization |
Cytoplasm and Nucleus |
AMACR + p63
|
13H4 + ZM70 |
0.5 ml |
Concentrate |
CE/IVD |
Z2008MRS |
-
|
Host |
Rabbit and Mouse |
Clone |
13H4 + ZM70 |
Format |
Concentrate |
Reactivity |
- |
Method |
P |
Positive control |
Prostate carcinoma. |
Dilution |
1:50 |
Isotype |
IgG, IgG1a/k |
Immunogen |
Human AMACR (P504S) and p63 polypeptides |
Localization |
Cytoplasm and Nucleus |
AMACR + p63
|
13H4 + ZM70 |
0.1 ml |
Concentrate |
CE/IVD |
Z2008MRT |
-
|
Host |
Rabbit + Mouse |
Clone |
13H4 + ZM70 + 34βE12 |
Format |
Concentrate |
Reactivity |
- |
Method |
P |
Pretreatment |
Citrate or EDTA |
Positive control |
Prostate intraepithelial neoplasia (PIN) |
Dilution |
1:50 |
Isotype |
IgG, IgG1 + IgG2a |
Immunogen |
Human AMACR (P504S) , p63, and CKHMW (34βE12) polypeptides |
Localization |
Cytoplasm and Nucleus |
AMACR + p63 + HMW CK Cocktail
|
13H4 + ZM70 + 34βE12 |
1 ml |
Concentrate |
CE/IVD |
Z2015MRL |
-
|
Host |
Rabbit + Mouse |
Clone |
13H4 + ZM70 + 34βE12 |
Format |
Ready-to-use |
Reactivity |
- |
Method |
P |
Pretreatment |
Citrate or EDTA |
Positive control |
Prostate intraepithelial neoplasia (PIN) |
Dilution |
- |
Isotype |
IgG, IgG1 + IgG2a |
Immunogen |
Human AMACR (P504S) , p63, and CKHMW (34βE12) polypeptides |
Localization |
Cytoplasm and Nucleus |
AMACR + p63 + HMW CK Cocktail
|
13H4 + ZM70 + 34βE12 |
7 ml |
Ready-to-use |
CE/IVD |
Z2015MRP |
-
|
Host |
Rabbit + Mouse |
Clone |
13H4 + ZM70 + 34βE12 |
Format |
Concentrate |
Reactivity |
- |
Method |
P |
Pretreatment |
Citrate or EDTA |
Positive control |
Prostate intraepithelial neoplasia (PIN) |
Dilution |
1:50 |
Isotype |
IgG, IgG1 + IgG2a |
Immunogen |
Human AMACR (P504S) , p63, and CKHMW (34βE12) polypeptides |
Localization |
Cytoplasm and Nucleus |
AMACR + p63 + HMW CK Cocktail
|
13H4 + ZM70 + 34βE12 |
0.5 ml |
Concentrate |
CE/IVD |
Z2015MRS |
-
|
Host |
Rabbit + Mouse |
Clone |
13H4 + ZM70 + 34βE12 |
Format |
Concentrate |
Reactivity |
- |
Method |
P |
Pretreatment |
Citrate or EDTA |
Positive control |
Prostate intraepithelial neoplasia (PIN) |
Dilution |
1:50 |
Isotype |
IgG, IgG1 + IgG2a |
Immunogen |
Human AMACR (P504S) , p63, and CKHMW (34βE12) polypeptides |
Localization |
Cytoplasm and Nucleus |
AMACR + p63 + HMW CK Cocktail
|
13H4 + ZM70 + 34βE12 |
0.1 ml |
Concentrate |
CE/IVD |
Z2015MRT |
-
|
Host |
Rabbit and Mouse |
Clone |
13H4+4A4 |
Format |
Concentrate |
Reactivity |
- |
Method |
P |
Positive control |
Prostate intraepithelial neoplasia (PIN) |
Dilution |
1:50 |
Isotype |
IgG, IgG2a/k |
Localization |
Cytoplasm and nucleus |
AMACR+p63
|
13H4+4A4 |
1.0 ml |
Concentrate |
RUO |
Z2005MRL-R |
-
|
Host |
Rabbit and Mouse |
Clone |
13H4+4A4 |
Format |
Ready-to-use |
Reactivity |
- |
Method |
P |
Positive control |
Prostate intraepithelial neoplasia (PIN) |
Dilution |
- |
Isotype |
IgG, IgG2a/k |
Localization |
Cytoplasm and nucleus |
AMACR+p63
|
13H4+4A4 |
7 ml |
Ready-to-use |
RUO |
Z2005MRP-R |
-
|
Host |
Rabbit and Mouse |
Clone |
13H4+4A4 |
Format |
Concentrate |
Reactivity |
- |
Method |
P |
Positive control |
Prostate intraepithelial neoplasia (PIN) |
Dilution |
1:50 |
Isotype |
IgG, IgG2a/k |
Localization |
Cytoplasm and nucleus |
AMACR+p63
|
13H4+4A4 |
0.5 ml |
Concentrate |
RUO |
Z2005MRS-R |
-
|
Host |
Rabbit and Mouse |
Clone |
13H4+4A4 |
Format |
Concentrate |
Reactivity |
- |
Method |
P |
Positive control |
Prostate intraepithelial neoplasia (PIN) |
Dilution |
1:50 |
Isotype |
IgG, IgG2a/k |
Localization |
Cytoplasm and nucleus |
AMACR+p63
|
13H4+4A4 |
0.1 ml |
Concentrate |
RUO |
Z2005MRT-R |
-
|
Host |
Rabbit and Mouse |
Clone |
13H4+4A4+34bE12 |
Format |
Concentrate |
Reactivity |
- |
Method |
P |
Positive control |
Prostate intraepithelial neoplasia (PIN) |
Dilution |
1:50 |
Isotype |
IgG, IgG2a + IgG1 |
Immunogen |
Human AMACR (P504S), p63, and CKHMW (34βE12) polypeptides |
Localization |
Cytoplasm and Nucleus |
AMACR+p63+HMW CK
|
13H4+4A4+34bE12 |
1ml |
Concentrate |
RUO |
Z2017MRL-R |
-
|
Host |
Rabbit and Mouse |
Clone |
13H4+4A4+34bE12 |
Format |
Ready-to-use |
Reactivity |
- |
Method |
P |
Positive control |
Prostate intraepithelial neoplasia (PIN) |
Dilution |
- |
Isotype |
IgG, IgG2a + IgG1 |
Immunogen |
Human AMACR (P504S), p63, and CKHMW (34βE12) polypeptides |
Localization |
Cytoplasm and Nucleus |
AMACR+p63+HMW CK
|
13H4+4A4+34bE12 |
7 ml |
Ready-to-use |
RUO |
Z2017MRP-R |
-
|
Host |
Rabbit and Mouse |
Clone |
13H4+4A4+34bE12 |
Format |
Concentrate |
Reactivity |
- |
Method |
P |
Positive control |
Prostate intraepithelial neoplasia (PIN) |
Dilution |
1:50 |
Isotype |
IgG, IgG2a + IgG1 |
Immunogen |
Human AMACR (P504S), p63, and CKHMW (34βE12) polypeptides |
Localization |
Cytoplasm and Nucleus |
AMACR+p63+HMW CK
|
13H4+4A4+34bE12 |
0.5 ml |
Concentrate |
RUO |
Z2017MRS-R |
-
|
Host |
Rabbit and Mouse |
Clone |
13H4+4A4+34bE12 |
Format |
Concentrate |
Reactivity |
- |
Method |
P |
Positive control |
Prostate intraepithelial neoplasia (PIN) |
Dilution |
1:50 |
Isotype |
IgG, IgG2a + IgG1 |
Immunogen |
Human AMACR (P504S), p63, and CKHMW (34βE12) polypeptides |
Localization |
Cytoplasm and Nucleus |
AMACR+p63+HMW CK
|
13H4+4A4+34bE12 |
0.1 ml |
Concentrate |
RUO |
Z2017MRT-R |
-
|
Host |
Sheep |
Clone |
polyclonal |
Format |
Purified |
Method |
WB, EL |
Isotype |
Sheep IgG |
Immunogen |
Native pancreatic amylase |
Amylase (Pancreas)
|
polyclonal |
1 ml |
Purified |
RUO |
601-0204 |
-
|
Host |
Rabbit |
Clone |
polyclonal |
Format |
Concentrate |
Method |
F, P |
Pretreatment |
Citrate |
Positive control |
Pancreas |
Dilution |
1:200 |
Isotype |
Rabbit IgG |
Immunogen |
Synthetic peptide derived from N-terminus of human Amylin peptide |
Localization |
Cytoplasm |
Amylin (Peptide)
|
polyclonal |
1 ml |
Concentrate |
RUO |
501-3404 |
-
|
Host |
Mouse |
Clone |
R10/99 |
Format |
TCS |
Method |
F, P |
Dilution |
1:100 |
Isotype |
Mouse IgG1 |
Immunogen |
CATQRLANFLV cuopled to tuberculin |
Amylin (Peptide)
|
R10/99 |
2 ml |
TCS |
RUO |
601-0206 |
-
|
Host |
Rabbit |
Clone |
Polyclonal |
Format |
Concentrate |
Method |
P |
Pretreatment |
Citrate |
Positive control |
Brain |
Dilution |
1:50 - 1:100 |
Localization |
Cytoplasm, extracellular |
Amyloid
|
Polyclonal |
1 ml |
Concentrate |
CE/IVD |
RP123 |
-
|
Host |
Rabbit |
Clone |
Polyclonal |
Format |
Concentrate |
Method |
P |
Pretreatment |
Citrate |
Positive control |
Brain |
Dilution |
1:50 - 1:100 |
Localization |
Cytoplasm, extracellular |
Amyloid
|
Polyclonal |
0.1 ml |
Concentrate |
CE/IVD |
RP123-01 |
-
|
Host |
Rabbit |
Clone |
Polyclonal |
Format |
Concentrate |
Method |
P |
Pretreatment |
Citrate |
Positive control |
Brain |
Dilution |
1:50 - 1:100 |
Localization |
Cytoplasm, extracellular |
Amyloid
|
Polyclonal |
0.5 ml |
Concentrate |
CE/IVD |
RP123-05 |
-
|
Host |
Mouse |
Clone |
mc1 |
Format |
Concentrate |
Method |
F, P |
Positive control |
Kidney |
Dilution |
1:10 - 1:25 |
Isotype |
Mouse IgG2a |
Localization |
Extracellular |
Amyloid A Component
|
mc1 |
1 ml |
Concentrate |
CE/IVD |
MOB003 |
-
|
Host |
Mouse |
Clone |
mc1 |
Format |
Concentrate |
Method |
F, P |
Positive control |
Kidney |
Dilution |
1:10 - 1:25 |
Isotype |
Mouse IgG2a |
Localization |
Extracellular |
Amyloid A Component
|
mc1 |
0.1 ml |
Concentrate |
CE/IVD |
MOB003-01 |
-
|
Host |
Mouse |
Clone |
mc1 |
Format |
Concentrate |
Method |
F, P |
Positive control |
Kidney |
Dilution |
1:10 - 1:25 |
Isotype |
Mouse IgG2a |
Localization |
Extracellular |
Amyloid A Component
|
mc1 |
0.5 ml |
Concentrate |
CE/IVD |
MOB003-05 |
-
|
Host |
Mouse |
Clone |
mc1 |
Format |
Ready-to-use |
Method |
F, P |
Positive control |
Kidney |
Dilution |
- |
Isotype |
Mouse IgG2a |
Localization |
Extracellular |
Amyloid A Component
|
mc1 |
6 ml |
Ready-to-use |
CE/IVD |
PDM118 |
-
|
Host |
Mouse |
Clone |
DE2B4 |
Format |
Purified |
Method |
WB, P, IP |
Pretreatment |
Enzyme |
Positive control |
Alzheimer´s disease brain |
Isotype |
Mouse IgG1 |
Immunogen |
Synthetic peptide consisting of residues 1-17 of the amyloid beta protein |
Amyloid Beta
|
DE2B4 |
100 µg |
Purified |
RUO |
601-0210 |
-
|
Host |
Rabbit |
Clone |
polyclonal |
Format |
Serum |
Method |
EL, WB, P |
Pretreatment |
Formic acid |
Positive control |
Alzheimer´s disease brain |
Isotype |
Rabbit IgG |
Amyloid Beta 1 - 40
|
polyclonal |
100 µl |
Serum |
RUO |
601-0211 |
-
|
Host |
Rabbit |
Clone |
polyclonal |
Format |
Serum |
Method |
EL, WB, P |
Pretreatment |
Formic acid |
Positive control |
Alzheimer´s disease brain |
Isotype |
Rabbit IgG |
Amyloid Beta 1 - 42
|
polyclonal |
100 µl |
Serum |
RUO |
601-0212 |
-
|
Host |
Rabbit |
Clone |
polyclonal |
Format |
Concentrate |
Reactivity |
DG, PG |
Method |
P |
Pretreatment |
Citrate |
Positive control |
Alzheimer's Brain |
Dilution |
1:100 |
Isotype |
Rabbit IgG |
Immunogen |
Synthetic peptide corresponding to N-terminal of human APP |
Localization |
Cytoplasmic, Extracellular |
Amyloid Beta Precursor Protein (APP)
|
polyclonal |
0.5 ml |
Concentrate |
RUO |
501-2652 |
-
|
Host |
Rabbit |
Clone |
polyclonal |
Format |
Concentrate |
Reactivity |
DG, PG |
Method |
P |
Pretreatment |
Citrate |
Positive control |
Alzheimer's Brain |
Dilution |
1:100 |
Isotype |
Rabbit IgG |
Immunogen |
Synthetic peptide corresponding to N-terminal of human APP |
Localization |
Cytoplasmic, Extracellular |
Amyloid Beta Precursor Protein (APP)
|
polyclonal |
1 ml |
Concentrate |
RUO |
501-2654 |
-
|
Host |
Mouse |
Clone |
BAM-10 |
Format |
Concentrate |
Method |
F, P |
Positive control |
Brain |
Dilution |
1:50 - 1:100 |
Isotype |
Mouse IgG1 |
Localization |
Cytoplasm |
Amyloid Beta Protein
|
BAM-10 |
1 ml |
Concentrate |
CE/IVD |
MOB410 |
-
|
Host |
Mouse |
Clone |
BAM-10 |
Format |
Concentrate |
Method |
F, P |
Positive control |
Brain |
Dilution |
1:50 - 1:100 |
Isotype |
Mouse IgG1 |
Localization |
Cytoplasm |
Amyloid Beta Protein
|
BAM-10 |
0.1 ml |
Concentrate |
CE/IVD |
MOB410-01 |
-
|
Host |
Mouse |
Clone |
BAM-10 |
Format |
Concentrate |
Method |
F, P |
Positive control |
Brain |
Dilution |
1:50 - 1:100 |
Isotype |
Mouse IgG1 |
Localization |
Cytoplasm |
Amyloid Beta Protein
|
BAM-10 |
0.5 ml |
Concentrate |
CE/IVD |
MOB410-05 |
-
|
Host |
Mouse |
Clone |
AR 441 |
Format |
Concentrate |
Method |
F, P |
Pretreatment |
Citrate |
Positive control |
Prostate Carcinoma |
Dilution |
1:25 - 1:50 |
Isotype |
Mouse IgG1 |
Localization |
Nucleus |
Androgen Receptor
|
AR 441 |
1 ml |
Concentrate |
CE/IVD |
MOB245 |
-
|
Host |
Mouse |
Clone |
AR 441 |
Format |
Concentrate |
Method |
F, P |
Pretreatment |
Citrate |
Positive control |
Prostate Carcinoma |
Dilution |
1:25 - 1:50 |
Isotype |
Mouse IgG1 |
Localization |
Nucleus |
Androgen Receptor
|
AR 441 |
0.1 ml |
Concentrate |
CE/IVD |
MOB245-01 |
-
|
Host |
Mouse |
Clone |
AR 441 |
Format |
Concentrate |
Method |
F, P |
Pretreatment |
Citrate |
Positive control |
Prostate Carcinoma |
Dilution |
1:25 - 1:50 |
Isotype |
Mouse IgG1 |
Localization |
Nucleus |
Androgen Receptor
|
AR 441 |
0.5 ml |
Concentrate |
CE/IVD |
MOB245-05 |
-
|
Host |
Mouse |
Clone |
AR 441 |
Format |
Ready-to-use |
Method |
F, P |
Pretreatment |
Citrate |
Positive control |
Prostate Carcinoma |
Dilution |
- |
Isotype |
Mouse IgG1 |
Localization |
Nucleus |
Androgen Receptor
|
AR 441 |
6 ml |
Ready-to-use |
CE/IVD |
PDM167 |
-
|
Host |
Rabbit |
Clone |
ZR334 |
Format |
Concentrate |
Reactivity |
- |
Method |
P |
Pretreatment |
Citrate or EDTA |
Positive control |
Prostate or Breast Carcinoma |
Dilution |
1:100 - 1:200 |
Isotype |
IgG |
Immunogen |
Synthetic peptide corresponding ti residues (within aa 1-100) of human Androgen Receptor |
Localization |
Nucleus |
Androgen Receptor (AR)
|
ZR334 |
1 ml |
Concentrate |
CE/IVD |
Z2640RL |
-
|
Host |
Rabbit |
Clone |
ZR334 |
Format |
Ready-to-use |
Reactivity |
- |
Method |
P |
Pretreatment |
Citrate or EDTA |
Positive control |
Prostate or Breast Carcinoma |
Dilution |
- |
Isotype |
IgG |
Immunogen |
Synthetic peptide corresponding ti residues (within aa 1-100) of human Androgen Receptor |
Localization |
Nucleus |
Androgen Receptor (AR)
|
ZR334 |
7 ml |
Ready-to-use |
CE/IVD |
Z2640RP |
-
|
Host |
Rabbit |
Clone |
ZR334 |
Format |
Concentrate |
Reactivity |
- |
Method |
P |
Pretreatment |
Citrate or EDTA |
Positive control |
Prostate or Breast Carcinoma |
Dilution |
1:100 - 1:200 |
Isotype |
IgG |
Immunogen |
Synthetic peptide corresponding ti residues (within aa 1-100) of human Androgen Receptor |
Localization |
Nucleus |
Androgen Receptor (AR)
|
ZR334 |
0.5 ml |
Concentrate |
CE/IVD |
Z2640RS |
-
|
Host |
Rabbit |
Clone |
ZR334 |
Format |
Concentrate |
Reactivity |
- |
Method |
P |
Pretreatment |
Citrate or EDTA |
Positive control |
Prostate or Breast Carcinoma |
Dilution |
1:100 - 1:200 |
Isotype |
IgG |
Immunogen |
Synthetic peptide corresponding ti residues (within aa 1-100) of human Androgen Receptor |
Localization |
Nucleus |
Androgen Receptor (AR)
|
ZR334 |
0.1 ml |
Concentrate |
CE/IVD |
Z2640RT |
-
|
Host |
Rabbit |
Clone |
polyclonal |
Format |
Purified |
Method |
WB, P |
Pretreatment |
Citrate |
Isotype |
Rabbit IgG |
Immunogen |
Synthetic peptide corresponding to a sequence within the amino acid terminus of human ACE2 |
Angiotensin Converting Enzyme 2 (ACE2)
|
polyclonal |
100 µg |
Purified |
RUO |
601-0006 |
-
|
Host |
Monospecific Mouse |
Clone |
ZM211 |
Format |
Concentrate |
Reactivity |
- |
Method |
P |
Pretreatment |
Citrate or EDTA |
Positive control |
Lymph node or hairy cell leukemia |
Dilution |
1:100 - 1:200 |
Isotype |
IgG2a /κ |
Immunogen |
Recombinant full-length human Annexin A1 protein |
Localization |
Nucleus, cytoplasm or cell membrane |
Annexin A1
|
ZM211 |
1 ml |
Concentrate |
CE/IVD |
Z2488ML |
-
|
Host |
Monospecific Mouse |
Clone |
ZM211 |
Format |
Ready-to-use |
Reactivity |
- |
Method |
P |
Pretreatment |
Citrate or EDTA |
Positive control |
Lymph node or hairy cell leukemia |
Dilution |
- |
Isotype |
IgG2a /κ |
Immunogen |
Recombinant full-length human Annexin A1 protein |
Localization |
Nucleus, cytoplasm or cell membrane |
Annexin A1
|
ZM211 |
7 ml |
Ready-to-use |
CE/IVD |
Z2488MP |
-
|
Host |
Monospecific Mouse |
Clone |
ZM211 |
Format |
Concentrate |
Reactivity |
- |
Method |
P |
Pretreatment |
Citrate or EDTA |
Positive control |
Lymph node or hairy cell leukemia |
Dilution |
1:100 - 1:200 |
Isotype |
IgG2a /κ |
Immunogen |
Recombinant full-length human Annexin A1 protein |
Localization |
Nucleus, cytoplasm or cell membrane |
Annexin A1
|
ZM211 |
0.5 ml |
Concentrate |
CE/IVD |
Z2488MS |
-
|
Host |
Monospecific Mouse |
Clone |
ZM211 |
Format |
Concentrate |
Reactivity |
- |
Method |
P |
Pretreatment |
Citrate or EDTA |
Positive control |
Lymph node or hairy cell leukemia |
Dilution |
1:100 - 1:200 |
Isotype |
IgG2a /κ |
Immunogen |
Recombinant full-length human Annexin A1 protein |
Localization |
Nucleus, cytoplasm or cell membrane |
Annexin A1
|
ZM211 |
0.1 ml |
Concentrate |
CE/IVD |
Z2488MT |
-
|
Host |
Rabbit |
Clone |
polyclonal |
Format |
Concentrate |
Reactivity |
PG, BV |
Method |
P |
Pretreatment |
Citrate |
Positive control |
Placenta |
Dilution |
1:25 |
Isotype |
Rabbit IgG |
Immunogen |
Synthetic peptide corresponding to N-terminus of human annexin 1 |
Localization |
Cell Membrane |
Annexin I (ANXA1)
|
polyclonal |
0.5 ml |
Concentrate |
RUO |
501-14032 |
-
|
Host |
Rabbit |
Clone |
polyclonal |
Format |
Concentrate |
Reactivity |
PG, BV |
Method |
P |
Pretreatment |
Citrate |
Positive control |
Placenta |
Dilution |
1:25 |
Isotype |
Rabbit IgG |
Immunogen |
Synthetic peptide corresponding to N-terminus of human annexin 1 |
Localization |
Cell Membrane |
Annexin I (ANXA1)
|
polyclonal |
1 ml |
Concentrate |
RUO |
501-14034 |
-
|
Host |
Rabbit |
Clone |
polyclonal |
Format |
Ready-to-use |
Method |
F, P |
Pretreatment |
Citrate |
Positive control |
Liver |
Dilution |
- |
Isotype |
Rabbit IgG |
Immunogen |
Synthetic peptide corresponding to aa 5 -23 of human Annexin VI. |
Localization |
Cell Membrane |
Annexin VI
|
polyclonal |
7 ml |
Ready-to-use |
RUO |
501-12381 |
-
|
Host |
Rabbit |
Clone |
polyclonal |
Format |
Concentrate |
Method |
WB, F, P |
Pretreatment |
Citrate |
Positive control |
Liver |
Dilution |
1:50 |
Isotype |
Rabbit IgG |
Immunogen |
Synthetic peptide corresponding to aa 5 -23 of human Annexin VI. |
Localization |
Cell Membrane |
Annexin VI
|
polyclonal |
1 ml |
Concentrate |
RUO |
501-12384 |
-
|